Nonacus Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 30, 2023 - 08:47 GMT

Nonacus Announces Strategic Partnership with Pronto Diagnostics to Expand Presence in Israel's Genomics Market

This collaboration signifies a strategic move to strengthen Nonacus' position in the rapidly evolving field of NGS and clinical genomics. BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, November 30, 2023 /⁨EINPresswire.com⁩/ -- Nonacus, pioneer in genetic …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 14:07 GMT

Grand Opening of Advanced Genomics APAC Taiwan Headquarters

Signals Strong Commitment to Innovative Medical Services Focused on Early Cancer Detection and Companion Testing TAIWAN, October 4, 2023 /⁨EINPresswire.com⁩/ -- Advanced Genomics APAC Co. Ltd. proudly announces the grand opening of its Taiwan headquarters …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 17, 2023 - 11:30 GMT

Liquid Biopsy Specialist Nonacus unveils new Birmingham Headquarters with Distinguished Presence of Angela Douglas MBE

BIRMINGHAM, WEST MIDLANDS, ENGLAND, May 17, 2023 /⁨EINPresswire.com⁩/ -- Liquid biopsy specialist Nonacus and genomic testing laboratory Informed Genomics officially opened their new Birmingham Headquarters yesterday with a ribbon-cutting ceremony led by …

Distribution channels: Business & Economy, Companies ...

Published on March 10, 2023 - 10:12 GMT

Nonacus launches GALEAS® Bladder, a novel test for the non-invasive detection of bladder cancer

The urine-based molecular test can quickly and accurately detect bladder cancer and streamline diagnosis, thereby reducing the need for invasive cystoscopies. BIRMINGHAM, UNITED KINGODM, March 10, 2023 /⁨EINPresswire.com⁩/ -- Nonacus, a liquid biopsy …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 26, 2023 - 10:00 GMT

Liquid Biopsy specialist Nonacus launches smaller custom panels for cost-effective detection of minimal residual disease

Nonacus has launched the Cell3™ Target: Custom MRD Panel for rapid and cost-effective minimal residual disease (MRD) detection and longitudinal monitoring. BIRMINGHAM, WEST MIDLANDS , UNITED KINGDOM, January 26, 2023 /⁨EINPresswire.com⁩/ -- Nonacus Ltd, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 24, 2022 - 10:30 GMT

Nonacus Ranked Third Fastest Growing Technology Company in the UK in the Deloitte Technology Fast 50

Nonacus today announced that it ranked number three in the 2022 Deloitte UK Technology Fast 50. BIRMINGHAM, WEST MIDLANDS , UNITED KINGDOM, November 24, 2022 /⁨EINPresswire.com⁩/ -- Nonacus today announced that it ranked number three in the 2022 Deloitte …

Distribution channels: Business & Economy, Companies ...